Broad Market, Sector, Thematic: Choosing Fund Scope

Fund scope describes how much of the market one product covers: broad-market funds hold thousands of companies across every industry, sector funds concentrate on a single industry, and thematic funds bet on one narrative slicing across industries - artificial intelligence, clean energy, aging populations. Scope is really a dial for concentration risk: each step narrower raises both potential reward and the probability of being spectacularly wrong. This guide maps the spectrum, exposes the overlap trap hiding in mixed portfolios, and defines where specialty sleeves can responsibly fit.

Three stops on the concentration dial

The overlap trap

Holdings: Total Market 90% + Tech Sector Fund 10%
Assume tech is ~30% of total-market index:
  Effective tech exposure = 0.90 x 30% + 0.10 x 100%
                          = 27% + 10% = 37%
You 'added' 10% tech; actual tilt added ~7 points
and your sector-fund fees bought mostly shares you owned
Check top-10 holdings overlaps before counting anything as new

Sector funds: concentrated but definable

Sector products carry one advantage over themes: industries have long operating histories, measurable cycles, and defined demand drivers. Betting on semiconductors means betting on a real economy with customers and earnings - risky but analyzable. That said, sector concentration historically amplified drawdowns badly during industry-specific busts, and timing entries well enough to matter has defeated most professionals. For most households, broad funds already own every sector, capitalization-weighted, which self-corrects as industries rise and fall.

Thematic funds: narratives versus cash flows

• Themes launch after performance, not before: product proliferation clusters near narrative peaks when investor enthusiasm - and fee tolerance - maxes out.
• Constituent turnover runs high; yesterday's theme champions get replaced quietly while the ticker name persists.
• Expense ratios typically run above broad equivalents because curation costs money and enthusiasm subsidizes it.
• Valuation discipline vanishes at launches: buying 'the future' rarely comes with a price check attached.
• None of this denies themes capture real trends eventually - it questions whether fund buyers at peak excitement capture them profitably.

Year 1-3: theme works, early adopters win quietly
Year 4: media coverage saturates; fund complexes launch products
Year 5: record inflows at elevated valuations
Year 6+: reality diverges from story; drawdown tests conviction
Question worth asking BEFORE year 4:
  'If this trend is obvious, why is it cheap?'

Where specialty sleeves legitimately fit

1. As deliberate tilts with written reasoning - 'I believe healthcare demographics beat the market' beats vague enthusiasm.
2. Sized as satellites: common convention keeps any single specialty sleeve to five-to-ten percent so being wrong dents rather than derails.
3. With rebalancing rules attached, forcing partial wins off the table mechanically instead of emotionally.
4. Inside accounts matching their tax character - high-turnover sleeves belong in shelters.
5. Only after the broad core exists fully; seasoning before the meal.

Questions before any narrow purchase

• What exactly does this fund own, and how much do I already own of it through broader holdings?
• What would prove this thesis wrong, and what is my pre-committed response?
• Am I paying up for exposure, or for excitement? Compare expense ratios honestly.
• If the theme arrives but the fund's picks miss it, do I still win? (Sometimes the answer is genuinely yes - know why.)
• Would I add to this at these valuations if it had launched last month instead of three years ago?

The bottom line